Lilly trades at a premium to Ozempic-maker Novo as obesity drugs boom
Does Eli Lilly deserve to trade at a premium to Novo Nordisk shares? For Deutsche Bank analyst James Shin, the ...
Does Eli Lilly deserve to trade at a premium to Novo Nordisk shares? For Deutsche Bank analyst James Shin, the ...
Elevated bond yields and geopolitical uncertainty continued to be negative for stocks this week as the overall market moved into ...
Our portfolio experienced a flurry of adjustments in a week dominated by Nvidia's (NVDA) quarterly results Wednesday evening and Federal ...
(*5*)In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for a few of our ...
Citi is bearish on lithium - not less than in the near future. That is because China's massive electric vehicle ...
[mailpoet_form id=”1″]
© 2022. All Right Reserved By Moneyoutlook.com